|
|  |
| Max Phase II |
|
| Summary of Proposed Investment |
| This Summary of Proposed Investment is prepared and distributed to the public in advance of the IFC Board of Directors’ consideration of the proposed transaction. Its purpose is to enhance the transparency of IFC’s activities, and this document should not be construed as presuming the outcome of the Board decision. Board dates are estimates only. |
| Project number | 25805 |
| Company name | Max Healthcare Institute Limted |
| Country | India |
| Sector | Health Care |
| Environmental category | B |
| Department | Health and Education |
| Status | Active |
|
| Date SPI disclosed | March 13, 2007 |
| Projected board date | May 10, 2007 |
| Date revised SPI disclosed | April 2, 2007 |
| Previous Events | Invested: July 20, 2007
Signed: June 29, 2007
Approved: May 24, 2007 |
|
| View Environmental & Social Review Summary (ESRS), click here |
|
| Overview |
Sponsor/Cost/Location |
Development Impact |
Contacts |
Attachments |
| Project description |
| The project consists of financing the expansion of Max Healthcare Institute (Max Healthcare or the company) in India over the next two to four years. Max Healthcare currently operates five hospitals primarily in the North Capital Region, which includes New Delhi and its approximate surroundings. The project includes adding about 452 beds to its existing 742 beds capacity and aims to address the strong demand for quality healthcare services in India and particularly in Delhi. Max Healthcare plans to expand its presence to about 1200 beds by 2010. |
|
| Project sponsor and major shareholders of project company |
| The project sponsor is Max India Ltd, a listed company (Bombay and National Stock Exchanges), which commenced operations in the 1980s. It is a multi-business company with interests in life insurance, healthcare, clinical research, specialty plastics and health staffing. It’s Chairman and founder, Analjit Singh, along with other promoters, owns 41% of Max India. The remaining shares in Max India are owned by foreign institutional/other investors and resident individuals. Max India owns 70% of Max Healthcare and Warburg Pincus is the other main shareholder of Max Healthcare with a 23% shareholding. |
| Total project cost and amount and nature of IFC's investment |
| The total project cost is estimated at $90.0 million. The proposed IFC investment is a $66.7 million equity and quasi-equity investment for IFC’s own account. |
| Location of project and description of site |
| The project comprises expansion of existing secondary and tertiary facilities as well as construction of new hospitals in the North Capital Region, which includes New Delhi and its approximate surroundings, and Dehradun, located 250km north of Delhi. |
|
| Anticipated development impact of the project |
| The project will expand healthcare infrastructure and thus provide greater access to quality healthcare services to increased numbers of patients in NCR and beyond Delhi. The project also complements the Government of India’s endeavors to expand access to healthcare, including provision of healthcare to government employees. It is also expected to create over 4500 jobs (medical industry and during the construction phase). |
 |
| IFC's expected development contribution |
| IFC’s equity investment would provide the company critical ‘breathing space’ in its important ramp-up growth period. The Sponsor and Company also value IFC’s global experience in financing healthcare companies and its expertise in and knowledge of the private healthcare sector in developing countries. It also recognizes that IFC, as a widely respected international financial institution, would bring credibility and discipline to the company as it approaches its proposed IPO. Further, IFC would be able to contribute to improving the corporate governance and environmental, social and insurance standards and operating practices of the company’s hospitals, in which the Sponsor has expressed interest. |
| Environmental and social issues - Category B |
While all Performance Standards are applicable to this investment, IFC’s environmental and social due diligence indicates that the investment will have impacts which must be managed in a manner consistent with the following Performance Standards:
- PS1: Social and Environmental Assessment and Management Systems with respect to corporate environmental, social, and health and safety management systems policies and procedures and their implementation across its existing and proposed operations, including national and local government permitting requirements;
- PS2: Labor and Working Conditions including occupational hygiene, health, safety and training programs and protocols for all employees, and specific measures for housekeeping, radiation, kitchen and other at-risk employees and contractors;
- PS3: Pollution Prevention and Abatement including environmental and social issues typical of health care projects such as air emissions and noise; water and wastewater; power (including fuel storage); hazardous materials management, storage, handling and disposal; and minimization, recycling and disposal of solid and hazardous wastes; and
- PS4: Community Health, Safety and Security including fire and life safety and emergency response, community consultation and disclosure, and corporate social responsibility efforts including HIV/AIDS awareness; and
- PS5: Land Acquisition and Involuntary Resettlement as applicable if land acquisition results in compensation payments and physical and/or economic resettlement.
Complete details on IFC’s Environmental and Social assessment of this project may be found in the Environmental and Social Review Summary prepared by IFC, which also will be made publicly available on the IFC website.
Environmental Documents will be made accessible at the following location:
Max House
3rd Floor, 1, Dr. Jha Marg, Okhla Phase III
New Delhi, 110-020 |
|
| For inquiries about the project, contact: |
Mr. B. Anantharaman, Director
Max Healthcare Institute Limited
Max House
3rd Floor, 1, Dr. Jha Marg, Okhla Phase III
New Delhi, 110-020
Telephone: +91 011 269 33618
Fax: +91 011 269 33620
E-mail: asingh@maxindia.com |
|
| For inquiries and comments about IFC, contact: |
General IFC Inquiries
IFC Corporate Relations
2121 Pennsylvania Avenue, NW
Washington DC 20433
Telephone: 202-473-3800
Fax: 202-974-4384
E Mail: Webmaster |
|
|
|
|